- What is the primary diagnostic advantage of performing this nested PCR procedure described in the passage?
Answer: It significantly increases the sensitivity for detecting low copy numbers of the target.
Nested PCR is a two-stage amplification process. The first round amplifies the target sequence, and the second round amplifies a region within that first product. This process dramatically increases the number of target molecules, making the assay much more sensitive than a single round of PCR. This is particularly useful for detecting pathogens present at very low levels, such as JC virus in CSF. While it also increases specificity (distractor D), its primary purpose and most significant advantage is the boost in sensitivity.
- A nasopharyngeal swab from a patient with flu-like symptoms is sent for molecular testing for Influenza A virus. The laboratory performs a standard PCR protocol using primers targeting the influenza matrix gene and reports a negative result. The positive control, a plasmid containing the target DNA sequence, amplified correctly. What is the most likely reason for this potentially false-negative result?
Answer: Influenza A is an RNA virus, and the protocol omitted the essential reverse transcriptase step to convert viral RNA to cDNA.
Influenza A is an RNA virus. Standard PCR amplifies DNA templates. To detect an RNA target, a reverse transcription (RT) step must be performed first to create a complementary DNA (cDNA) copy of the RNA genome. This cDNA then serves as the template for the PCR. The failure to include reverse transcriptase in the reaction protocol is a fundamental error that would prevent the detection of the virus, regardless of viral load or primer design. The DNA plasmid control worked because it did not require this step.
- Two identical PCR reactions are set up to amplify a target from human genomic DNA. Reaction A uses a standard Taq polymerase, while Reaction B uses a chemically-modified hot-start Taq polymerase. Both master mixes are fully assembled and left on the bench at room temperature for 30 minutes before cycling. What is the most likely difference to be observed on an agarose gel?
Answer: Reaction A is more likely to show non-specific bands and primer-dimers compared to Reaction B.
Standard Taq polymerase has some activity even at room temperature. During the time the reaction sits on the bench, primers can bind non-specifically to the template, and the polymerase can extend them, leading to non-specific products and primer-dimers. Hot-start polymerases are inactive at room temperature and are only activated by the initial high-temperature denaturation step. This prevents the amplification of mis-primed products, resulting in a cleaner reaction with higher specificity.
- A patient undergoing antiviral therapy for Hepatitis B virus (HBV) is monitored by qPCR. The initial pre-therapy sample had a Ct value of 21. A sample taken one month after starting therapy has a Ct value of 24. Assuming the assay has near 100% amplification efficiency, what is the most accurate interpretation of this change?
Answer: The viral load has decreased by approximately 8-fold.
In qPCR, the Ct value is inversely proportional to the logarithm of the initial target concentration. At 100% efficiency, the amount of DNA doubles with each cycle. Therefore, a difference of 1 Ct represents a 2-fold change, 2 Cts a 4-fold (2²) change, and 3 Cts an 8-fold (2³) change. Since the Ct value increased from 21 to 24 (a change of +3 cycles), the initial amount of viral DNA must have decreased by a factor of 2³, or 8-fold. This indicates a positive response to therapy.
- An RT-qPCR assay is used to detect SARS-CoV-2 RNA in a nasopharyngeal swab. The patient sample is negative for the viral target. The endogenous internal control targeting human RNase P mRNA is also negative (undetermined Ct) in the patient sample, while it amplifies correctly in the external positive control. What is the most likely pre-analytical cause of this result?
Answer: Significant degradation of RNA in the patient sample prior to or during extraction.
The internal control targeting a human mRNA serves as a control for the entire process, from sample collection to amplification. Its failure to amplify in the patient sample, while working in the positive control, points to a problem with the patient sample itself. Since both the viral RNA and the human mRNA targets failed, the most plausible explanation is that all RNA in the sample was compromised. RNA is highly labile and can be easily degraded if the sample is not collected, stored, or processed correctly. This would result in the failure of both targets.
- A patient with non-small cell lung cancer is being monitored for the emergence of a rare T790M resistance mutation in the EGFR gene using circulating tumor DNA (ctDNA) from plasma. Why would digital PCR (dPCR) be a more suitable method than qPCR for this specific clinical application?
Answer: dPCR provides absolute quantification without the need for a standard curve, enabling precise measurement of rare alleles.
Digital PCR works by partitioning the sample into thousands of individual reaction chambers, such that most contain either zero or one template molecule. This partitioning allows for the direct counting of positive reactions, providing absolute quantification without a standard curve. This method is exceptionally sensitive and precise for detecting rare events, such as a low-frequency resistance mutation (T790M) against a high background of wild-type DNA, which is a common challenge when analyzing ctDNA.
- During optimization of a new PCR assay, the annealing temperature is increased by 5°C above the calculated primer melting temperature (Tm), and the annealing time is shortened. How will these modifications most likely affect the assay's performance characteristics?
Answer: Specificity will likely increase, while sensitivity may decrease.
Increasing the annealing temperature and decreasing the annealing time increases the stringency of the reaction. This means that only primer-template matches that are nearly perfect will be stable enough to initiate synthesis. As a result, non-specific binding is reduced, leading to an increase in specificity. However, this high stringency may also prevent some valid, but slightly mismatched, primer binding, or may not allow enough time for all specific binding to occur, potentially reducing the overall yield and thus decreasing the sensitivity of the assay.
- A multiplex PCR assay is designed to detect both Legionella pneumophila (target size 300 bp) and Mycoplasma pneumoniae (target size 180 bp). When a control sample containing equal concentrations of both target DNAs is amplified, gel analysis shows a very strong 180 bp band but only a faint, barely visible 300 bp band. What is the most probable cause of this observation?
Answer: The primers for the 180 bp target are significantly more efficient than the primers for the 300 bp target.
In multiplex PCR, different primer sets compete for the same pool of reagents (polymerase, dNTPs). If one primer set has a higher binding affinity or initiates synthesis more efficiently than another, it will dominate the reaction. The preferential amplification of the smaller amplicon suggests that its corresponding primers are outcompeting the primers for the larger target. This can be due to differences in Tm, GC content, or secondary structure of the primers or template.
- A real-time PCR assay using SYBR Green dye is performed to detect Mycobacterium tuberculosis complex DNA. The positive control yields a single, sharp melting peak at 88.5°C. A patient sample is positive with a Ct of 25, but its melt curve analysis reveals a single, sharp peak at 82.0°C. The no-template control is negative. How should this result be interpreted?
Answer: The amplification product in the patient sample is likely a non-specific artifact or primer-dimer, not the intended target.
Melt curve analysis is used to assess the specificity of a SYBR Green qPCR reaction. The melting temperature (Tm) is dependent on the GC content and length of the amplicon. A significant shift in Tm (6.5°C in this case) between the patient sample and the positive control indicates that a different DNA product was amplified. This is most likely a non-specific product or a primer-dimer, meaning the positive Ct value does not represent a true positive for M. tuberculosis.
- A laboratory is converting its SYBR Green-based qPCR assay for Bordetella pertussis to a probe-based hydrolysis (e.g., TaqMan) assay that targets the same genetic sequence. What is the primary analytical advantage gained by making this change?
Answer: Increased specificity, as signal is generated only from amplification of the intended target.
The main advantage of a probe-based system like TaqMan over an intercalating dye like SYBR Green is increased specificity. SYBR Green binds to any double-stranded DNA, including non-specific products and primer-dimers. A hydrolysis probe is a sequence-specific oligonucleotide that must bind to the target amplicon between the primers for a signal to be generated. This adds a third level of specificity beyond the two primers, ensuring that only amplification of the correct target is detected.
- A standard curve was generated for a quantitative PCR assay by plotting the Ct values against the logarithm of the starting quantity of a serial dilution of a DNA standard. The resulting linear regression equation was y = -3.55x + 42.1, with an R² value of 0.995. Based on the slope of this line, what is the calculated amplification efficiency of this assay?
Answer: The efficiency is approximately 91%, which is within the acceptable range for a diagnostic assay.
The amplification efficiency (E) of a qPCR reaction can be calculated from the slope of the standard curve using the formula E = (10−1/slope) - 1. In this case, E = (10−1/−3.55) - 1 = (100.2817) - 1 ≈ 1.913 - 1 = 0.913, or 91.3%. An efficiency between 90% and 110% is generally considered acceptable. The R² value indicates the linearity and precision of the dilutions, not the efficiency of the amplification reaction itself. - A clinical laboratory performs a quantitative PCR (qPCR) assay to detect Neisseria gonorrhoeae in a urine sample. The patient sample shows a cycle threshold (Ct) value of 38 for the N. gonorrhoeae target. The internal control, amplifying the human RNase P gene, shows a Ct value of 35 in the same sample; this control typically amplifies at a Ct of 28. The no-template control is negative. What is the most appropriate interpretation and subsequent action?
Answer: The result is indeterminate due to evidence of PCR inhibition or poor nucleic acid extraction; re-extraction and re-testing are required.
The correct interpretation is that the result is indeterminate. A high Ct value for the internal control (35 vs. the typical 28) indicates a problem with the sample itself, such as the presence of PCR inhibitors or inefficient nucleic acid extraction. This systemic issue affects both the target and control amplification, making the late Ct value for the N. gonorrhoeae target uninterpretable. The proper course of action is to obtain a new aliquot of the sample for re-extraction and re-testing.
- A patient is tested for whooping cough using a PCR assay targeting the IS*481* insertion element, which is highly abundant in Bordetella pertussis. The PCR is positive. However, subsequent DNA sequencing of the amplicon reveals a sequence identical to that found in Bordetella holmesii, which can also carry the IS*481* element and cause similar symptoms. This finding represents a limitation in which performance characteristic of the PCR assay?
Answer: Analytical specificity
Analytical specificity refers to the ability of an assay to detect only the target of interest and not cross-react with other, closely related organisms or sequences. In this case, the assay correctly amplified the IS*481* target, but because this target is not unique to Bordetella pertussis, the assay cross-reacted with Bordetella holmesii. This is a failure of analytical specificity, as the test did not exclusively identify the intended pathogen.
- A high-volume clinical laboratory experiences recurrent false-positive results in its qualitative PCR assay for Chlamydia trachomatis, suggesting carryover contamination from previous amplification products. Which of the following biochemical modifications to the PCR protocol is the most effective strategy to prevent this specific type of contamination?
Answer: Incorporating dUTP instead of dTTP into the PCR master mix and pre-treating subsequent reactions with Uracil-DNA Glycosylase (UNG).
The UNG system is a standard method for preventing carryover contamination. PCR products are synthesized using dUTP in place of dTTP. Before a new PCR is started, the reaction is incubated with UNG, which degrades any DNA containing uracil (i.e., amplicons from previous reactions). The UNG is then heat-inactivated during the initial denaturation step, so it does not affect the newly synthesized amplicons. This specifically destroys contaminant amplicons without affecting the template DNA from the patient sample.
- A PCR-based assay is used to amplify a specific gene from Helicobacter pylori from a gastric biopsy. The resulting PCR product will be sent for Sanger sequencing to identify mutations associated with antibiotic resistance. Which type of DNA polymerase is most critical to use in this PCR reaction to ensure the accuracy of the downstream sequencing result?
Answer: A high-fidelity polymerase with 3'-to-5' exonuclease (proofreading) activity.
When the PCR product is to be sequenced to detect specific mutations, accuracy is paramount. Standard Taq polymerase lacks proofreading activity and has a relatively high error rate (about 1 in 10,000 bases). These introduced errors can obscure the true sequence of the template DNA. A high-fidelity polymerase possesses 3'-to-5' exonuclease activity, which corrects errors made during DNA synthesis, resulting in a much lower error rate and a more accurate representation of the original sequence.
- A PCR assay designed to amplify a 250 bp fragment of the mecA gene in MRSA is performed. The gel electrophoresis results show a bright 250 bp band for the positive control and no bands for the no-template control. The patient sample, however, shows no band at 250 bp but displays a distinct, sharp band at approximately 50 bp. What is the most likely explanation for the result in the patient sample?
Answer: The patient sample is negative for the mecA gene, and the low molecular weight band is a primer-dimer artifact.
Primer-dimers are artifacts formed by the annealing of primers to each other. They are typically small (usually <100 bp) and form preferentially when there is no specific template to which the primers can bind. The absence of the 250 bp target band and the presence of a small ~50 bp band is classic evidence of primer-dimer formation in a negative sample. The other options are less likely: a 200 bp deletion is massive and improbable, DNA degradation typically leads to no amplification or a smear, and incomplete products would also likely form a smear rather than a sharp band.
- A technologist is troubleshooting a PCR assay that failed to produce an amplicon for both the patient sample and the positive control. The no-template control was also blank as expected. Upon reviewing the master mix preparation, the technologist realizes that magnesium chloride (MgCl₂) was omitted. What is the direct biochemical consequence of this omission?
Answer: The DNA polymerase is catalytically inactive as it requires Mg²⁺ as an essential cofactor.
DNA polymerases, including Taq polymerase, are metalloenzymes that require a divalent cation, typically Mg²⁺, as a cofactor. The Mg²⁺ ions are crucial for the catalytic activity of the enzyme, as they interact with the dNTPs and the phosphate backbone of the DNA. Without Mg²⁺, the polymerase cannot function, and no DNA synthesis will occur. While Mg²⁺ also affects primer annealing and DNA stability, its role as a direct and essential cofactor for the polymerase is the primary reason for complete reaction failure.